8-11486464-C-T

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The ENST00000645242.1(BLK) variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. Note: ENST00000645242.1 is not a MANE Select or MANE Plus Clinical transcript for BLK; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.259 (AC=39,418) in the gnomAD database across 152,104 control chromosomes, including 6,491 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.696. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 6491 hom., cov: 32)

Consequence

BLK
ENST00000645242.1 upstream_gene

Predictors

3
AlphaGenome AVI: 1 : Benign

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.878

Publications

210 publications found
Genes affected
BLK (HGNC:1057): (BLK proto-oncogene, Src family tyrosine kinase) This gene encodes a nonreceptor tyrosine-kinase of the src family of proto-oncogenes that are typically involved in cell proliferation and differentiation. The protein has a role in B-cell receptor signaling and B-cell development. The protein also stimulates insulin synthesis and secretion in response to glucose and enhances the expression of several pancreatic beta-cell transcription factors. [provided by RefSeq, Aug 2010]
BLK Gene-Disease associations (from GenCC):
  • common variable immunodeficiency
    Inheritance: AD Classification: MODERATE Submitted by: PanelApp Australia
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young type 11
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • monogenic diabetes
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000645242.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available; Germline computational verdict: benign (Strong)
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6964 — exceeds 5% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000645242.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

There are no transcript annotations for this variant.

Ensembl Transcripts

BLK ENST00000645242.1
HGVSc / HGVSp
Exon rankN/A
upstream_gene
Prot:
BLK ENST00000696154.2
HGVSc / HGVSp
Exon rankN/A
upstream_gene
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.259
AC:39383
Hom:6471
AN:151986
Cov:32
GnomAD4 genome
AF: 0.259
AC:39418
Hom:6491
AN:152104
Cov:32
TOPMed (Bravo)
AF: 0.274
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.263
AC:186917
Hom:28163
AN:710204
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.266
AC:624
Hom:80
AN:2342
ChinaMAP Phase 1
AF: 0.731
Denmark Genome
AF: 0.263
AC:79
AN:300
GenomeAsia100K
AF: 0.534
AC:1855
AN:3478
Korea4K (4,157 Koreans)
AF: 0.727
AC:5253
AN:7230
Qatari Genome
AF: 0.256
AC:45
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.693
AC:85027
Hom:29474
AN:122752
Turkish Variome
AF: 0.272
AC:421
Hom:55
AN:1546
UK10K
AF: 0.259
AC:1956
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.731
AC:6550
Hom:2367
AN:8960
Showing 14 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign1.4
BayesDel_noAF
Benign-0.92
CADD
Benign3.1
DANN
Benign0.72
GPN-Star LLR
N/A-1.4
GPN-Star score
N/A1.4
PhyloP100
Benign0.88
PromoterAI
N/A-0.0080Neutral
Showing 8 of 8 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.